LDLRAD2 promotes pancreatic cancer progression through Akt/mTOR signaling pathway
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s12032-020-01451-0.pdf
Reference23 articles.
1. Maitra A. Pancreatic cancer hidden in plain sight. Nature. 2020;581(7806):34–5.
2. Kozlowski MR, Kozlowski RE. A novel, small peptide with activity against human pancreatic cancer. Am J Cancer Res. 2020;10(5):1356–65.
3. Ye J, et al. PRDM3 attenuates pancreatitis and pancreatic tumorigenesis by regulating inflammatory response. Cell Death Dis. 2020;11(3):187.
4. Menini S, et al. Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in Kras(G12D/+) mice. J Exp Clin Cancer Res. 2020;39(1):152.
5. Wei Y, et al. LDLRAD2 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/beta-catenin/EMT signaling cascade in gastric cancer. Aging (Albany NY). 2019;11(20):8951–68.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CircRNA PGAM1 Promotes the Migration and Invasion of Pancreatic Adenocarcinoma Cells by Activating the AKT/mTOR Signaling Pathway;Molecular Biotechnology;2023-09-13
2. METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS;Oncology Reports;2023-03-22
3. Overexpression of SFXN1 indicates poor prognosis and promotes tumor progression in lung adenocarcinoma;Pathology - Research and Practice;2022-09
4. Knockdown of FBI-1 Inhibits the Warburg Effect and Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeted Agents via miR-3692/HIF-1α;Frontiers in Oncology;2021-11-12
5. Identification of phosphoenolpyruvate carboxykinase 1 as a potential therapeutic target for pancreatic cancer;Cell Death & Disease;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3